Related Experiment Video
Updated: Jan 23, 2026

Population and Single-Cell Analysis of Antibiotic Persistence in Escherichia coli
Published on: March 24, 2023
The association between fluconazole dose and MIC with mortality and persistence in candidemia
Nesrin Ghanem-Zoubi1, Majd Qasum2, Johad Khoury3
1Infectious Diseases Institute, Rambam Health Care Campus, Ha-aliya 8 St, 3109601, Haifa, Israel. n_ghanem@rambam.health.gov.il.
Abstract:
To evaluate the association between fluconazole exposure parameters and clinical outcomes in patients with candidemia. We retrospectively included all adults with candidemia in a single center from January 2009 to December 2017, treated initially with fluconazole for fluconazole-susceptible candidemia. We assessed the association between fluconazole exposure parameters and 30-day mortality or 14-day clinical failure, a composite of mortality at day 14 or persistent candidemia ≥ 72 h, in all patients and in patients with C. glabrata candidemia. During the study period, 158 patients fulfilled the inclusion criteria. Main species were C. albicans 66 (41.8%), C. glabrata 35 (22.2%), and C. parapsilosis 31 (19.6%). Sixty patients (38%) died within 30 days. Sixty-one patients (38.6%) experienced 14-day failure. In 30-day survivors, the median AUC24/MIC was 2279 [398, 5989] versus 1764 [238, 6714] h in non-survivors, p = 0.75. Median fluconazole MIC was 0.75 [0.25, 4] and 1 [0.22, 5.50] mg/L, p = 0.54, respectively. Similar non-significant differences were found for other fluconazole exposure parameters and in the 14-day clinical failure analysis. For C. glabrata, a higher AUC24/MIC was observed among 30-day survivors with a median of 230 [77, 539] compared to 96 [75, 164] h in non-survivors, p = 0.008, in parallel with a trend for lower MIC values (median 7 [1, 2] versus 16 [8, 24] mg/L, p = 0.06, respectively). Currently used fluconazole dosing has no association with clinical outcome in Candida with low MIC values. For Candida species with high MICs, attention to dosing is needed.
Insights
Fluconazole dosing is not associated with outcomes in patients with low minimum inhibitory concentration (MIC) candidemia. However, careful dosing is needed for Candida species with high MICs to improve clinical outcomes.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Pharmacokinetics
Background:
- Candidemia, a serious fungal infection, requires effective antifungal treatment.
- Fluconazole is a common antifungal, but its efficacy can be influenced by drug exposure and fungal susceptibility.
- Understanding the relationship between fluconazole exposure and clinical outcomes is crucial for optimizing patient care.
Purpose of the Study:
- To investigate the association between fluconazole exposure parameters and clinical outcomes in patients with candidemia.
- To analyze this association specifically in patients with Candida glabrata candidemia.
- To determine if current fluconazole dosing strategies are adequate for all Candida species.
Main Methods:
- Retrospective analysis of adult patients with fluconazole-susceptible candidemia from 2009-2017.
- Assessment of fluconazole exposure parameters (AUC24/MIC) and clinical outcomes (30-day mortality, 14-day clinical failure).
- Stratified analysis for Candida albicans, Candida glabrata, and Candida parapsilosis, with a focus on C. glabrata.
Main Results:
- No significant association was found between fluconazole exposure parameters and 30-day mortality or 14-day clinical failure in the overall patient group.
- For Candida glabrata, a higher AUC24/MIC was observed in 30-day survivors compared to non-survivors (p=0.008).
- A trend towards lower fluconazole MIC values was noted in survivors with C. glabrata candidemia.
Conclusions:
- Current fluconazole dosing regimens are not associated with clinical outcomes in candidemia caused by Candida species with low minimum inhibitory concentrations (MICs).
- For Candida species exhibiting high MICs, particularly C. glabrata, optimizing fluconazole dosing is necessary to improve treatment efficacy.
- Further research into individualized dosing strategies based on fungal susceptibility is warranted for better management of candidemia.
Related Concept Videos
Dose Size and Dosing Frequency: Determination Methods
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
Association Areas of the Cortex
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...
Associative Learning
Classical conditioning, also known...
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
Dose-Response Relationship: Overview

